Strongbridge Biopharma plc to Report Second Quarter 2021 Financial Results on August 5, 2021
DUBLIN, Ireland and TREVOSE, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it will report the Company’s second quarter 2021 financial results and corporate highlights on August 5, 2021 at 7:30 a.m. ET.
About Strongbridge Biopharma
Corporate and Media Relations
Real World MSP Use Case
NB-IoT: Real-world Cases that Power a World of Possibilities
Staying Cold Lessons in Cold Chain Transit